For ovarian cancer, the cumulative cancer risk to age 80 years is estimated to be 44% (95% CI = 36–53%) and 17% (95% CI = 11–25%) for BRCA1 and BRCA2 pathogenic variant carriers, respectively (Kuchenbaecker et al., 2017). The gene discussed is BRCA2; the disease is ovarian cancer.